Biocon Receives 5 USFDA Observations at Bengaluru Biosimilars Site Written By Parthika Patel30 April 2026 7:52 PM ISTNew Delhi: Biocon Limited has announced that the United States Food and Drug Administration (USFDA) has completed a Pre-License Inspection (PLI) at...
Biocon Secures Health Canada Nod for Denosumab Biosimilars Bosaya, Vevzuo Written By sheeba farhat21 April 2026 11:45 PM ISTBengaluru: Biocon Limited has received a Notice of Compliance (NOC) from Health Canada for its denosumab biosimilars Bosaya and Vevzuo, marking a...
Govt Plans CDSCO Restructuring, 1,500+ Subject Experts to Be Hired Written By sheeba farhat14 April 2026 8:01 PM ISTNew Delhi: India is best positioned to play a leading role as the global pharmaceutical landscape evolves with increasing emphasis on biologics,...
Sun Pharma Plans USD 12 Billion Organon Acquisition, Prepares Binding Bid: Report Written By Parthika Patel10 April 2026 9:46 PM ISTMumbai: Sun Pharmaceutical Industries is preparing to submit a binding offer of around USD 12 billion to acquire Organon & Co., in what could...
Aurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in Europe Written By Parthika Patel26 March 2026 11:53 PM ISTHyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, CuraTeQ Biologics Pvt Ltd, has entered into a marketing and...
UK MHRA to Allow Drug Reviews Without Animal Testing by 2026, Issues Draft Framework Written By sheeba farhat26 March 2026 11:19 PM ISTBengaluru: Britain's medicines regulator said on Wednesday it will introduce ​a framework by the ​end of 2026, which would allow drugmakers to ask ​a...
Sun Pharma Rules Out Big-Bang Acquisitions, Bets on Organic Growth and Biosimilars Written By sheeba farhat9 Feb 2026 3:12 PM ISTThe drug major has consistently indicated that it wants to remain disciplined about acquisition, Shanghvi said.
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial Metrics Written By sheeba farhat28 Jan 2026 10:45 AM ISTNew Delhi: S&P Global Ratings has upgraded the long-term issuer credit rating of Biocon Biologics Limited to 'BB+' from 'BB' and revised the...
Aurobindo Arm CuraTeQ Gets Health Canada NOC for Pegfilgrastim Biosimilar Dyrupe Written By Farhat Nasim9 Jan 2026 11:36 PM ISTHyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has received a Notice of Compliance (NOC) from...
Biocon Biologics Eyes USD 75 Billion Oncology Market, Adds 3 New Biosimilar Drugs Written By Parthika Patel7 Jan 2026 4:37 PM ISTThese products are among the largest oncology biologics expected to lose exclusivity over the next five years.
Zydus Lifesciences Reports Rs 6,573.7 Cr Revenue in Q1 FY26, Net Profit Rises 3% Parthika Patel14 Aug 2025 2:00 PM ISTNew Delhi: Zydus Lifesciences Limited has announced its unaudited consolidated financial results for the first quarter ended June 30, 2025, reporting...
Alkem unveils Cetuximab under the Brand Name Cetuxa in India Written By Dr. Nandita Mohan31 May 2023 11:23 AM ISTMumbai: One of India's leading drug makers, Alkem Labs, has announced the launch of the world's first Cetuximab biosimilar in the country under the...
